JOHNSON & JOHNSON - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 119 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
JOHNSON & JOHNSON ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,637,491
-20.4%
394,8340.0%0.97%
-5.5%
Q2 2023$3,312,657
-15.5%
394,8340.0%1.03%
-19.3%
Q1 2023$3,920,702
+142574.7%
394,8340.0%1.28%
+59.4%
Q4 2022$2,748
-99.9%
394,8340.0%0.80%
+29.0%
Q3 2022$2,108,000
+33.8%
394,8340.0%0.62%
+54.2%
Q2 2022$1,575,000
-10.3%
394,8340.0%0.40%
+21.1%
Q1 2022$1,755,000
+11.1%
394,8340.0%0.33%
+84.4%
Q4 2021$1,579,000
-54.5%
394,8340.0%0.18%
-40.8%
Q3 2021$3,467,000394,8340.30%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,031,915$20,253,19221.02%
Perceptive Advisors 11,350,085$75,818,5682.53%
JOHNSON & JOHNSON 394,834$2,637,4910.97%
Joseph P. Lucia & Associates, LLC 28,331$189,2510.13%
WOODSTOCK CORP 137,179$916,3560.12%
Palo Alto Investors LP 160,800$1,074,1440.10%
Affinity Asset Advisors, LLC 44,348$296,2450.08%
Verition Fund Management LLC 935,273$6,247,6240.07%
FOX RUN MANAGEMENT, L.L.C. 33,519$223,9070.07%
TOBIAS FINANCIAL ADVISORS, INC. 34,173$228,2760.06%
View complete list of ALDEYRA THERAPEUTICS INC shareholders